Aptevo Therapeutics APVO
NASDAQ APVO
$1.62 +0.00 (+0.31%)
As of: Oct 21, 2026 · 1:36 PM EDT

Aptevo Therapeutics (APVO) Long-Term Debt Repayments (2020 - 2023)

Updated

Aptevo Therapeutics (APVO) reported Long-Term Debt Repayments of $3.47 million for FY2023, down 71.7% from $12.27 million in FY2022.

Analysis

Aptevo Therapeutics (APVO) Long-Term Debt Repayments (2020 - 2023) Analysis & Trends

Dating back to FY2020, Aptevo Therapeutics' Long-Term Debt Repayments record includes 4 years.

  • Long-Term Debt Repayments has a three-year compound annual growth rate of -46.1% (FY2020 to FY2023).
  • According to Business Quant data, Long-Term Debt Repayments came in at $12.27 million in FY2022 (+16.3%), $10.55 million in FY2021 (-52.3%) and $22.1 million in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 873.00 Mn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 1.00 Mn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 2.00 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 5.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 20.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 2.46 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 17.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Aptevo Therapeutics 1.94 Mn -65.06 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 3.47 Mn
Dec 31, 2022 500,000.00
Sep 30, 2022 500,000.00
Jun 30, 2022 500,000.00
Mar 31, 2022 10.77 Mn
Mar 31, 2020 22.10 Mn
API Access

Aptevo Therapeutics Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=APVO&period=max&api_key=YOUR_API_KEY